Quantum Cyber N.V. SEC filings QUCY
Quantum Cyber N.V. has 204 filings in SEC EDGAR's recent list, going back to Aug 3, 2021. Its latest annual report, Form ARS, was filed on Jun 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Jun 1, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2025 | Dec 31, 2024 |
| 20-F | Annual report (foreign issuer) | Apr 9, 2024 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | Apr 7, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | May 3, 2022 | Dec 31, 2021 |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QUCY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Mainz
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1874252
- Former names
- MAINZ BIOMED N.V. (until Apr 15, 2026); Mainz Biomed B.V. (until Nov 12, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.